Read about Endologix
in the news

Embrace the evidence.

The Latest:

One-Year Results of the DETOUR2 Trial published in the Journal of Vascular Surgery (JVS)

See Release

All News


Endologix Announces that Scott Ward Joins Board of Directors

Endologix announces the U. S. Centers for Medicare & Medicaid Services granted a Transitional Pass-Through (TPT) Payment for the DETOUR™ System

Endologix to Present in Two Upcoming Healthcare Conferences.

Endologix Announces Results of Pooled Analysis of DETOUR1 and DETOUR2 Studies at 2023 VIVA Late-Breaking Clinical Trial Session

Endologix’s DETOURTM System Earns Spot in Local and National Award Forums; Nominated for Prix Galien USA’s Best Medical Technology